Related Experiment Video
Updated: Sep 30, 2025

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Angiotensin II and AT1a Receptors in the Proximal Tubules of the Kidney: New Roles in Blood Pressure Control and
Ana Paula de Oliveira Leite1,2, Xiao C Li1,2, Sarah M Nwia1,2
1Tulane Hypertension and Renal Center of Excellence, 1430 Tulane Avenue, New Orleans, LA 70112, USA.
Insights
Hypertension is a major health issue. New mouse models show that targeting specific kidney tubule genes, like AT1a receptors and NHE3, can control blood pressure and reduce hypertension risk.
Area of Science:
- Nephrology
- Cardiovascular Physiology
- Genetics
Background:
- Hypertension affects 46% of US adults, increasing risks for heart attack, stroke, and kidney disease.
- Mechanisms of poorly controlled hypertension are not fully understood.
- The Cre/LoxP system allows gene function studies in specific tissues.
Purpose of the Study:
- Review findings from proximal tubule-specific genetically modified mouse models.
- Elucidate the role of Angiotensin II (Ang II) and AT1a receptors in blood pressure regulation.
- Investigate the impact of proximal tubule Ang II signaling on hypertension.
Main Methods:
- Utilized Cre/LoxP technology to create mouse models with altered gene function in proximal tubules.
- Generated models with selective deletion or overexpression of AT1a receptors and NHE3.
- Assessed effects on basal blood pressure, pressure-natriuresis, and Ang II-induced hypertension.
Main Results:
- Proximal tubule AT1a receptor or NHE3 deletion lowered blood pressure and enhanced natriuresis.
- Overexpression of Ang II or AT1a receptors increased sodium reabsorption and blood pressure.
- Hypertension development was attenuated in mice with deleted AT1a receptors or NHE3 in proximal tubules.
Conclusions:
- Intratubular Ang II signaling via AT1a receptors and NHE3 in proximal tubules is crucial for blood pressure homeostasis.
- Targeting these pathways in proximal tubules offers potential therapeutic strategies for hypertension.
Abstract:
Contrary to public perception, hypertension remains one of the most important public health problems in the United States, affecting 46% of adults with increased risk for heart attack, stroke, and kidney diseases. The mechanisms underlying poorly controlled hypertension remain incompletely understood. Recent development in the Cre/LoxP approach to study gain or loss of function of a particular gene has significantly helped advance our new insights into the role of proximal tubule angiotensin II (Ang II) and its AT1 (AT1a) receptors in basal blood pressure control and the development of Ang II-induced hypertension. This novel approach has provided us and others with an important tool to generate novel mouse models with proximal tubule-specific loss (deletion) or gain of the function (overexpression). The objective of this invited review article is to review and discuss recent findings using novel genetically modifying proximal tubule-specific mouse models. These new studies have consistently demonstrated that deletion of AT1 (AT1a) receptors or its direct downstream target Na+/H+ exchanger 3 (NHE3) selectively in the proximal tubules of the kidney lowers basal blood pressure, increases the pressure-natriuresis response, and induces natriuretic responses, whereas overexpression of an intracellular Ang II fusion protein or AT1 (AT1a) receptors selectively in the proximal tubules increases proximal tubule Na+ reabsorption, impairs the pressure-natriuresis response, and elevates blood pressure. Furthermore, the development of Ang II-induced hypertension by systemic Ang II infusion or by proximal tubule-specific overexpression of an intracellular Ang II fusion protein was attenuated in mutant mice with proximal tubule-specific deletion of AT1 (AT1a) receptors or NHE3. Thus, these recent studies provide evidence for and new insights into the important roles of intratubular Ang II via AT1 (AT1a) receptors and NHE3 in the proximal tubules in maintaining basal blood pressure homeostasis and the development of Ang II-induced hypertension.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Hormonal Regulation
Antihypertensive Drugs: Action of β1 Blockers
Hypertension and Regulation of Blood Pressure

